ARDELYX, INC. Accounts Payable
ARDELYX, INC. (ARDX) had Accounts Payable of $38.41 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $38.41M.
- 2026-03-31: Accounts Payable, Current $28.20M.
- 2025-12-31: Accounts Payable, Current $19.23M.
- 2025-09-30: Accounts Payable, Current $18.39M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $38.41M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $28.20M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $19.23M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $18.39M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $21.68M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $13.72M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $16.00M 10-K · filed 2026-02-19 |
| 2024-09-30 | $15.82M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $10.88M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $17.28M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $11.14M 10-K · filed 2025-02-20 |
| 2023-09-30 | $7.74M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $5.29M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $10.51M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $10.86M 10-K · filed 2024-02-22 |
| 2022-09-30 | $3.11M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.29M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.03M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.28M 10-K · filed 2023-03-02 |
| 2021-09-30 | $4.26M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.59M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $5.38M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.63M 10-K · filed 2022-02-28 |
| 2020-09-30 | $2.49M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.21M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.01M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.19M 10-K · filed 2021-03-08 |
| 2019-09-30 | $2.69M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.26M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.92M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.15M 10-K · filed 2020-03-06 |
| 2018-09-30 | $2.27M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $3.17M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.76M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.93M 10-K · filed 2019-03-06 |
| 2017-09-30 | $1.72M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $4.71M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $5.89M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $5.63M 10-K · filed 2018-03-14 |
| 2016-09-30 | $6.30M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $4.75M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $4.88M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $2.78M 10-K · filed 2017-02-17 |
| 2015-09-30 | $2.71M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.68M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $2.54M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $3.13M 10-K · filed 2016-03-04 |
| 2014-09-30 | $1.02M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $2.31M 10-Q · filed 2014-08-08 |
| 2013-12-31 | $2.28M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |